Feigin VL, Brainin M, Norrving B, Martins S, Sacco RL, Hacke W, et al. World Stroke Organization (WSO): global stroke fact sheet 2022. Int J Stroke. 2022;17:18–29.

Article  PubMed  Google Scholar 

Paul S, Candelario-Jalil E. Emerging neuroprotective strategies for the treatment of ischemic stroke: an overview of clinical and preclinical studies. Exp Neurol. 2021;335:113518.

Article  CAS  PubMed  Google Scholar 

Jayaraj RL, Azimullah S, Beiram R, Jalal FY, Rosenberg GA. Neuroinflammation: friend and foe for ischemic stroke. J Neuroinflamm. 2019;16:142.

Article  Google Scholar 

Liao S, Wu J, Liu R, Wang S, Luo J, Yang Y, et al. A novel compound DBZ ameliorates neuroinflammation in LPS-stimulated microglia and ischemic stroke rats: role of Akt(Ser473)/GSK3beta(Ser9)-mediated Nrf2 activation. Redox Biol. 2020;36:101644.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jia H, Qi X, Fu L, Wu H, Shang J, Qu M, et al. NLRP3 inflammasome inhibitor ameliorates ischemic stroke by reprogramming the phenotype of microglia/macrophage in a murine model of distal middle cerebral artery occlusion. Neuropathology. 2022;42:181–9.

Article  CAS  PubMed  Google Scholar 

Ge Y, Wang L, Wang C, Chen J, Dai M, Yao S, et al. CX3CL1 inhibits NLRP3 inflammasome-induced microglial pyroptosis and improves neuronal function in mice with experimentally-induced ischemic stroke. Life Sci. 2022;300:120564.

Article  CAS  PubMed  Google Scholar 

Luo L, Liu M, Fan Y, Zhang J, Liu L, Li Y, et al. Intermittent theta-burst stimulation improves motor function by inhibiting neuronal pyroptosis and regulating microglial polarization via TLR4/NFkappaB/NLRP3 signaling pathway in cerebral ischemic mice. J Neuroinflamm. 2022;19:141.

Article  CAS  Google Scholar 

Sapkota A, Choi JW. Oleanolic acid provides neuroprotection against ischemic stroke through the inhibition of microglial activation and NLRP3 inflammasome activation. Biomol Ther (Seoul). 2022;30:55–63.

Article  CAS  PubMed  Google Scholar 

Gonzalez HFJ, Yengo-Kahn A, Englot DJ. Vagus nerve stimulation for the treatment of epilepsy. Neurosurg Clin N Am. 2019;30:219–30.

Article  PubMed  PubMed Central  Google Scholar 

Tang H, Li J, Zhou Q, Li S, Xie C, Niu L, et al. Vagus nerve stimulation alleviated cerebral ischemia and reperfusion injury in rats by inhibiting pyroptosis via alpha7 nicotinic acetylcholine receptor. Cell Death Discov. 2022;8:54.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jiang Y, Li L, Tan X, Liu B, Zhang Y, Li C. miR-210 mediates vagus nerve stimulation-induced antioxidant stress and anti-apoptosis reactions following cerebral ischemia/reperfusion injury in rats. J Neurochem. 2015;134:173–81.

Article  CAS  PubMed  Google Scholar 

Dawson J, Liu CY, Francisco GE, Cramer SC, Wolf SL, Dixit A, et al. Vagus nerve stimulation paired with rehabilitation for upper limb motor function after ischaemic stroke (VNS-REHAB): a randomised, blinded, pivotal, device trial. Lancet. 2021;397:1545–53.

Article  PubMed  PubMed Central  Google Scholar 

Liu Y, Xu S, Zhang H, Qian K, Huang J, Gu X, et al. Stimulation of alpha7-nAChRs coordinates autophagy and apoptosis signaling in experimental knee osteoarthritis. Cell Death Dis. 2021;12:448.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 1989;20:84–91.

Article  CAS  PubMed  Google Scholar 

Schaar KL, Brenneman MM, Savitz SI. Functional assessments in the rodent stroke model. Exp Transl Stroke Med. 2010;2:13.

Article  PubMed  PubMed Central  Google Scholar 

Shi M, Cao L, Cao X, Zhu M, Zhang X, Wu Z, et al. DR-region of Na+/K+ ATPase is a target to treat excitotoxicity and stroke. Cell Death Dis. 2018;10:6.

Article  PubMed  PubMed Central  Google Scholar 

Cao L, Xiong S, Wu Z, Ding L, Zhou Y, Sun H, et al. Anti-Na+/K+-ATPase immunotherapy ameliorates alpha-synuclein pathology through activation of Na+/K+-ATPase alpha1-dependent autophagy. Sci Adv. 2021;7:eabc5062.

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Clements RT, Fuller LE, Kraemer KR, Radomski SA, Hunter-Chang S, Hall WC, et al. Quantification of neurite degeneration with enhanced accuracy and efficiency in an in vitro model of Parkinson’s disease. eNeuro. 2022;9:ENEURO.0327–21.2022.

Article  CAS  PubMed  Google Scholar 

Zhu M, Cao L, Xiong S, Sun H, Wu Z, Bian JS. Na+/K+-ATPase-dependent autophagy protects brain against ischemic injury. Signal Transduct Target Ther. 2020;5:55.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Luo Y, Reis C, Chen S. NLRP3 inflammasome in the pathophysiology of hemorrhagic stroke: a review. Curr Neuropharmacol. 2019;17:582–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brahadeeswaran S, Sivagurunathan N, Calivarathan L. Inflammasome signaling in the aging brain and age-related neurodegenerative diseases. Mol Neurobiol. 2022;59:2288–304.

Article  CAS  PubMed  Google Scholar 

Matta JA, Gu S, Davini WB, Bredt DS. Nicotinic acetylcholine receptor redux: discovery of accessories opens therapeutic vistas. Science. 2021;373:eabg6539.

Article  CAS  PubMed  Google Scholar 

Paul SM, Yohn SE, Popiolek M, Miller AC, Felder CC. Muscarinic acetylcholine receptor agonists as novel treatments for schizophrenia. Am J Psychiatry. 2022;179:611–27.

Article  PubMed  Google Scholar 

Theofani E, Semitekolou M, Samitas K, Mais A, Galani IE, Triantafyllia V, et al. TFEB signaling attenuates NLRP3-driven inflammatory responses in severe asthma. Allergy. 2022;77:2131–46.

Article  CAS  PubMed  Google Scholar 

Swanson KV, Deng M, Ting JP. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat Rev Immunol. 2019;19:477–89.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang Y, Leak RK, Cao G. Microglia-mediated neuroinflammation and neuroplasticity after stroke. Front Cell Neurosci. 2022;16:980722.

Article  PubMed  PubMed Central  Google Scholar 

Huffman WJ, Subramaniyan S, Rodriguiz RM, Wetsel WC, Grill WM, Terrando N. Modulation of neuroinflammation and memory dysfunction using percutaneous vagus nerve stimulation in mice. Brain Stimul. 2019;12:19–29.

Article  PubMed  Google Scholar 

Voet S, Srinivasan S, Lamkanfi M, van Loo G. Inflammasomes in neuroinflammatory and neurodegenerative diseases. EMBO Mol Med. 2019;11:e10248.

Article  PubMed  PubMed Central  Google Scholar 

Wang L, Ren W, Wu Q, Liu T, Wei Y, Ding J, et al. NLRP3 inflammasome activation: a therapeutic target for cerebral ischemia-reperfusion injury. Front Mol Neurosci. 2022;15:847440.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bonaz B, Picq C, Sinniger V, Mayol JF, Clarencon D. Vagus nerve stimulation: from epilepsy to the cholinergic anti-inflammatory pathway. Neurogastroenterol Motil. 2013;25:208–21.

Article  CAS  PubMed  Google Scholar 

Su Y, Zhang W, Zhang R, Yuan Q, Wu R, Liu X, et al. Activation of cholinergic anti-inflammatory pathway ameliorates cerebral and cardiac dysfunction after intracerebral hemorrhage through autophagy. Front Immunol. 2022;13:870174.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhao XP, Zhao Y, Qin XY, Wan LY, Fan XX. Non-invasive vagus nerve stimulation protects against cerebral ischemia/reperfusion injury and promotes microglial M2 polarization via interleukin-17A inhibition. J Mol Neurosci. 2019;67:217–26.

Article  CAS  PubMed  Google Scholar 

Ekici F, Karson A, Dillioglugil MO, Gurol G, Kir HM, Ates N. The effects of vagal nerve stimulation in focal cerebral ischemia and reperfusion model. Turk Neurosurg. 2013;23:451–7.

PubMed  Google Scholar